GS
XGN icon

GWN Securities’s Exagen XGN Stock Holding History

GWN Securities’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
+78,034
New +$294K 0.06% 369

Other funds holding XGN

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GWN Securities's XGN Position: Q2 2026 in Review

GWN Securities opened a new position in Exagen (XGN) in Q2 2026: 78,034 shares worth $363K. The stake represents 0.06% of the portfolio and ranks #369 among its holdings.

15 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • GWN Securities held 78,034 shares of Exagen worth $363K as of Q2 2026.
  • Exagen was a new GWN Securities position in Q2 2026.
  • Exagen made up 0.06% of GWN Securities's portfolio in Q2 2026, its #369 holding.
  • 15 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.